Perth headquartered bio-nanotech company pSivida Ltd is looking to raise $29 million through a non-renounceable rights issue to fund clinical trials for two of its treatments.
03/05/2006 - 11:13
pSivida to raise $29m to fund clinical trials
03/05/2006 - 11:13
